Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Gagnon

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Current Medical Research and Opinion|January 23, 2024
Patient journey of civilian adults diagnosed with posttraumatic stress disorder-A chart review studyLori L Davis, Annette Urganus, Patrick Gagnon-Sanschagrin, et al.
Infection and Immunity|May 16, 2019
Design and Characterization of Protein E-PilA, a Candidate Fusion Antigen for Nontypeable Haemophilus influenzae VaccineNormand Blais, Don Somers, Denis Faubert, et al.
Medicine|March 20, 2026
Real-world clinical and economic burden of immunoglobulin-G4-related disease in the United States: A retrospective claims-based analysisZachary S Wallace, Jenny Y Park, Elizabeth Serra, et al.
The Journal of Clinical Psychiatry|April 29, 2022
The Economic Burden of Posttraumatic Stress Disorder in the United States From a Societal PerspectiveLori L Davis, Jeff Schein, Martin Cloutier, et al.
Journal of Drugs in Dermatology : JDD|December 1, 2018
Adverse Medical Conditions Across Treatment Options in Patients With Psoriasis: A Claims-Based AnalysisJashin Wu, April Armstrong, Rakesh Singh, et al.
Clinical Lung Cancer|March 28, 2026
Brief Report: Treatment Patterns and Outcomes in a Large Real-World Cohort of Patients With ES-SCLC Treated With First-Line Chemoimmunotherapy in the United StatesXiuning Le, Elizabeth Serra, Kaitlyn Easson, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 5, 2019
Institutionalization risk and costs associated with agitation in Alzheimer's diseaseMartin Cloutier, Marjolaine Gauthier-Loiselle, Patrick Gagnon-Sanschagrin, et al.
Medicine|March 20, 2026
Burden of glucocorticoid use in commercially insured adults with generalized myasthenia gravis in the United States: A retrospective claims-based analysisNicholas J Silvestri, Jenny Y Park, Elizabeth Serra, et al.
Advances in Therapy|July 30, 2023
The Economic Burden of Adults with Major Depressive Disorder in the United States (2019)Paul Greenberg, Abhishek Chitnis, Derek Louie, et al.
Advances in Therapy|August 30, 2018
Burden of Infections Among Chronic Myeloid Leukemia Patients Receiving Dasatinib or Nilotinib: A Real-World Retrospective Healthcare Claims Study in the United StatesKaren Seiter, Dominick Latremouille-Viau, Annie Guerin, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Current Medical Research and Opinion|January 23, 2024
Patient journey of civilian adults diagnosed with posttraumatic stress disorder-A chart review studyLori L Davis, Annette Urganus, Patrick Gagnon-Sanschagrin, et al.
Infection and Immunity|May 16, 2019
Design and Characterization of Protein E-PilA, a Candidate Fusion Antigen for Nontypeable Haemophilus influenzae VaccineNormand Blais, Don Somers, Denis Faubert, et al.
Medicine|March 20, 2026
Real-world clinical and economic burden of immunoglobulin-G4-related disease in the United States: A retrospective claims-based analysisZachary S Wallace, Jenny Y Park, Elizabeth Serra, et al.
The Journal of Clinical Psychiatry|April 29, 2022
The Economic Burden of Posttraumatic Stress Disorder in the United States From a Societal PerspectiveLori L Davis, Jeff Schein, Martin Cloutier, et al.
Journal of Drugs in Dermatology : JDD|December 1, 2018
Adverse Medical Conditions Across Treatment Options in Patients With Psoriasis: A Claims-Based AnalysisJashin Wu, April Armstrong, Rakesh Singh, et al.
Clinical Lung Cancer|March 28, 2026
Brief Report: Treatment Patterns and Outcomes in a Large Real-World Cohort of Patients With ES-SCLC Treated With First-Line Chemoimmunotherapy in the United StatesXiuning Le, Elizabeth Serra, Kaitlyn Easson, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 5, 2019
Institutionalization risk and costs associated with agitation in Alzheimer's diseaseMartin Cloutier, Marjolaine Gauthier-Loiselle, Patrick Gagnon-Sanschagrin, et al.
Medicine|March 20, 2026
Burden of glucocorticoid use in commercially insured adults with generalized myasthenia gravis in the United States: A retrospective claims-based analysisNicholas J Silvestri, Jenny Y Park, Elizabeth Serra, et al.
Advances in Therapy|July 30, 2023
The Economic Burden of Adults with Major Depressive Disorder in the United States (2019)Paul Greenberg, Abhishek Chitnis, Derek Louie, et al.
Advances in Therapy|August 30, 2018
Burden of Infections Among Chronic Myeloid Leukemia Patients Receiving Dasatinib or Nilotinib: A Real-World Retrospective Healthcare Claims Study in the United StatesKaren Seiter, Dominick Latremouille-Viau, Annie Guerin, et al.
Pageof 6